Skip to main content

Peer Review reports

From: Identification of SPRYD4 as a tumour suppressor predicts prognosis and correlates with immune infiltration in cholangiocarcinoma

Original Submission
30 Jan 2023 Submitted Original manuscript
9 Feb 2023 Author responded Author comments - Binglu Li
6 Mar 2023 Reviewed Reviewer Report
13 Mar 2023 Reviewed Reviewer Report
20 Mar 2023 Author responded Author comments - Binglu Li
Resubmission - Version 2
9 Feb 2023 Submitted Manuscript version 2
24 Mar 2023 Author responded Author comments - Binglu Li
Resubmission - Version 3
24 Mar 2023 Submitted Manuscript version 3
Publishing
5 Apr 2023 Editorially accepted
4 May 2023 Article published 10.1186/s12885-023-10810-9

You can find further information about peer review here.

Back to article page